- ISIN
- US40131M1099
- CUSIP
- 40131M109
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Oct 4, 2018
Highlights
- Market Cap
- $16.91B
- Enterprise Value
- $17.60B
- EPS (TTM)
- -$3.40
- Total Revenue (TTM)
- $1.08B
- Gross Profit (TTM)
- $701.01M
- EBITDA (TTM)
- -$411.42M
- Year Range
- $40.36 - $135.00
- Target Price
- $133.14
- ROA (TTM)
- -22.62%
- ROE (TTM)
- 239.24%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GH Performance Chart
Guardant Health, Inc. (GH) is up 26.1% since the beginning of the year. At $129 per share, GH is trading 4.6% below its 52-week high of $135. Investors who bought $1,000 worth of GH shares 5 years ago would now be looking at an investment worth $1,010.
Loading charts...
Returns By Period
Guardant Health, Inc. (GH) has returned 26.13% so far this year and 162.17% over the past 12 months.
Guardant Health, Inc.
- 1D
- -2.24%
- 1M
- 8.31%
- YTD
- 26.13%
- 6M
- 27.13%
- 1Y
- 162.17%
- 3Y*
- 53.63%
- 5Y*
- 0.19%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
GH Monthly Returns History
Based on dividend-adjusted daily data since Oct 4, 2018, GH's average daily return is +0.17%, while the average monthly return is +3.66%. At this rate, an investment would double in approximately 1.6 years.
Historically, 52% of months were positive and 48% were negative. The best month was Feb 2019 with a return of +65.2%, while the worst month was Dec 2022 at -48.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 10 months.
On a daily basis, GH closed higher 50% of trading days. The best single day was Dec 3, 2018 with a return of +28.6%, while the worst single day was Dec 16, 2022 at -27.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.65% | -17.66% | -1.63% | -5.73% | 48.93% | -0.66% | 26.13% | ||||||
| 2025 | 53.78% | -9.43% | 0.12% | 10.87% | -14.00% | 28.11% | -21.25% | 64.52% | -7.33% | 48.88% | 16.56% | -5.79% | 234.34% |
| 2024 | -18.93% | -13.36% | 8.58% | -12.75% | 50.56% | 6.57% | 21.64% | -27.18% | -10.32% | -4.62% | 62.75% | -14.21% | 12.94% |
| 2023 | 15.55% | -1.72% | -24.12% | -3.75% | 29.96% | 22.10% | 8.99% | 0.15% | -24.16% | -12.69% | -2.74% | 7.47% | -0.55% |
| 2022 | -30.46% | -4.72% | -0.05% | -6.85% | -33.58% | -1.56% | 24.37% | -0.22% | 7.53% | -8.04% | 5.74% | -48.03% | -72.81% |
| 2021 | 20.65% | -5.35% | 3.72% | 4.15% | -21.93% | 0.06% | -11.59% | 15.91% | -1.78% | -6.58% | -9.99% | -4.85% | -22.39% |
Benchmark Metrics
Guardant Health, Inc. has an annualized alpha of 27.08%, beta of 1.34, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since October 04, 2018.
- This stock captured 151.71% of S&P 500 Index gains and 114.84% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 27.08%
- Beta
- 1.34
- R²
- 0.15
- Upside Capture
- 151.71%
- Downside Capture
- 114.84%
Return for Risk
Risk / Return Rank
GH ranks 92 for risk / return — in the top 92% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Guardant Health, Inc. (GH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +0.83 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.37 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 4.95 | 2.78 | +2.16 |
| Martin ratioReturn relative to average drawdown | 12.27 | 12.44 | -0.17 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Guardant Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Guardant Health, Inc. was 91.03%, occurring on Apr 19, 2024. The portfolio has not yet recovered.
The current Guardant Health, Inc. drawdown is 28.07%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -91.03%Apr 2024 | 3y 2mo | — | 5y 4moFeb 2021 - now |
COVID crash2020 | -46.47%Mar 2020 | 7mo 10d | 6mo 13d | 1y 1moAug 2019 - Sep 2020 |
2019 bear market2019 | -34.74%Apr 2019 | 1mo 5d | 3mo 17d | 4mo 22dMar 2019 - Aug 2019 |
Rate-hike selloffLate 2018 | -29.44%Dec 2018 | 17d | 1mo 22d | 2mo 9dDec 2018 - Feb 2019 |
Rate-hike selloffLate 2018 | -19.99%Oct 2018 | 11d | 1mo 5d | 1mo 16dOct 2018 - Dec 2018 |
Drawdown Indicators
| GH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.03% | -56.78% | -34.25% |
Max Drawdown (1Y)Largest decline over 1 year | -32.98% | -9.10% | -23.88% |
Max Drawdown (3Y)Largest decline over 3 years | -59.79% | -18.90% | -40.89% |
Max Drawdown (5Y)Largest decline over 5 years | -87.84% | -25.43% | -62.41% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -28.07% | -1.80% | -26.27% |
Average DrawdownAverage peak-to-trough decline | -51.50% | -10.71% | -40.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.27% | 2.03% | +11.24% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Guardant Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Guardant Health, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GH relative to other companies in the Diagnostics & Research industry. Currently, GH has a P/S ratio of 15.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with GH
Add Guardant Health, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GH